| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tonapofylline | adenosine a1 receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
1.95 | phase 2 | unknown |
| tonapofylline | adenosine receptor a1 | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
1.95 | investigational | antagonist |
| tonapofylline | adenosine receptor a1 | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
1.95 | investigational | unknown |
| tonapofylline | adenosine a1 receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
1.95 | phase 2 | antagonist |
| tonapofylline | adenosine a2a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
0.61 | phase 2 | antagonist |
| tonapofylline | adenosine a2a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
0.61 | phase 2 | unknown |
| tonapofylline | adenosine a2b receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
0.86 | phase 2 | unknown |
| tonapofylline | adenosine a2b receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
0.86 | phase 2 | antagonist |
| tonapofylline | adenosine a3 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
0.8 | phase 2 | antagonist |
| tonapofylline | adenosine a3 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] |
0.8 | phase 2 | unknown |
| click here to return to the previous page | ||||||||